Ruolun Qiu

Director
Pfizer, Inc

Poster(s):

• (T-003) Simultaneous Modeling of Ponsegromab PK, PD and Clinical Response in Patients with Cancer Cachexia
  Tuesday, October 21, 2025

  7:00 AM - 1:45 PM MDT